Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $433.16 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $115.68 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $90.60 | 1 | $0 (2019) |
| Horizon Therapeutics plc | $79.81 | 5 | $0 (2023) |
| Melinta Therapeutics, LLC | $67.36 | 4 | $0 (2021) |
| Paratek Pharmaceuticals, Inc. | $40.73 | 2 | $0 (2024) |
| ConvaTec Inc. | $22.45 | 1 | $0 (2024) |
| Zyla Life Sciences | $16.53 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.82 | 2 | ConvaTec Inc. ($22.45) |
| 2023 | $17.49 | 1 | Horizon Therapeutics plc ($17.49) |
| 2022 | $20.14 | 1 | Horizon Therapeutics plc ($20.14) |
| 2021 | $72.04 | 4 | Horizon Therapeutics plc ($29.82) |
| 2020 | $135.39 | 3 | Smith+Nephew, Inc. ($115.68) |
| 2019 | $147.28 | 5 | Novartis Pharmaceuticals Corporation ($90.60) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 05/28/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ANTIBIOTIC | ||||||
| 11/27/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: KRYSTEXXA | ||||||
| 10/27/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: KRYSTEXXA | ||||||
| 09/14/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: KRYSTEXXA | ||||||
| 05/24/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: KRYSTEXXA | ||||||
| 03/16/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: ANTIBIOTIC | ||||||
| 01/13/2021 | Melinta Therapeutics, LLC | Orbactiv (Drug), Vabomere, Minocin | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: ANTIBIOTICS | ||||||
| 11/05/2020 | Melinta Therapeutics, LLC | Orbactiv (Drug), Vabomere, Minocin IV | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: ANTIBIOTICS | ||||||
| 10/28/2020 | Smith+Nephew, Inc. | GRAFIX PL (Biological) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Other Advanced Wound Management | ||||||
| 03/10/2020 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $86.02 | General |
| Category: Pharma Product | ||||||
| 10/30/2019 | Zyla Life Sciences | SPRIX (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Pain Medicine | ||||||
| 10/16/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: ANTIBIOTICS | ||||||
| 09/25/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $90.60 | General |
| 08/22/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ANTIBIOTICS | ||||||
| 03/26/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 400 | 895 | $111,932 | $43,728 |
| 2022 | 5 | 519 | 1,148 | $102,477 | $54,218 |
| 2021 | 6 | 785 | 1,950 | $173,363 | $100,446 |
| 2020 | 5 | 744 | 1,093 | $126,132 | $45,547 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 387 | $62,696 | $24,429 | 39.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 154 | 381 | $30,669 | $12,112 | 39.5% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 34 | 54 | $7,629 | $3,115 | 40.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 39 | 51 | $6,519 | $2,398 | 36.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,420 | $1,674 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 191 | 490 | $52,865 | $29,725 | 56.2% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 202 | 493 | $32,583 | $15,117 | 46.4% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 42 | 67 | $6,389 | $3,759 | 58.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 48 | 62 | $4,921 | $3,002 | 61.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $5,719 | $2,615 | 45.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 280 | 808 | $86,876 | $54,364 | 62.6% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2021 | 300 | 839 | $55,391 | $27,871 | 50.3% |
| 11056 | Removal of 2 to 4 thickened skin growths | Office | 2021 | 65 | 125 | $11,920 | $7,293 | 61.2% |
| 11055 | Removal of single thickened skin growth | Office | 2021 | 70 | 108 | $8,572 | $5,506 | 64.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 59 | 59 | $9,280 | $4,727 | 50.9% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 11 | 11 | $1,324 | $683.76 | 51.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 257 | 422 | $52,480 | $20,261 | 38.6% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2020 | 298 | 469 | $45,106 | $14,390 | 31.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 68 | 68 | $11,934 | $4,857 | 40.7% |
| 11056 | Removal of 2 to 4 thickened skin growths | Office | 2020 | 72 | 83 | $10,929 | $4,031 | 36.9% |
| 11055 | Removal of single thickened skin growth | Office | 2020 | 49 | 51 | $5,683 | $2,008 | 35.3% |
About Dr. Lillian Loretz, DPM
Dr. Lillian Loretz, DPM is a Podiatrist healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356376743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lillian Loretz, DPM has received a total of $433.16 in payments from pharmaceutical and medical device companies, with $40.82 received in 2024. These payments were reported across 16 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($433.16).
As a Medicare-enrolled provider, Loretz has provided services to 2,448 Medicare beneficiaries, totaling 5,086 services with total Medicare billing of $243,940. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Podiatrist
- Location Savannah, GA
- Active Since 07/12/2006
- Last Updated 03/03/2014
- Taxonomy Code 213E00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356376743
Products in Payments
- Santyl (Drug) $86.02
- KRYSTEXXA (Biological) $79.81
- NUZYRA (Drug) $40.73
- Orbactiv (Drug) $39.57
- GRAFIX PL (Biological) $29.66
- Baxdela (Drug) $27.79
- INNOVAMATRIX AC (Device) $22.45
- SPRIX (Drug) $16.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Podiatrist Doctors in Savannah
Dr. Ido Friedman, D.p.m, D.P.M
Podiatrist — Payments: $2,248
Dr. Craig Skalla, Dpm, DPM
Podiatrist — Payments: $1,322
Dr. Kayli Hurst, Dpm, DPM
Podiatrist — Payments: $281.19
Steven Pangborn, Dpm, DPM
Podiatrist — Payments: $47.31
Dr. Angeline Dy, Dpm, DPM
Podiatrist — Payments: $14.83
Dr. Paul Horovitz, Dpm, DPM
Podiatrist